New assay predicts myeloma survival
New assay predicts myeloma survival
Epigenetic reprogramming of bone marrow mesenchymal stem cells in multiple myeloma
Whole genome sequencing reveals underlying genetics of multiple myeloma
Myeloma bone disease: background and latest
New data in the diagnosis and prognosis of multiple myeloma
Relapse and retreatment of multiple myeloma
Mutiple myeloma treatment in the non-transplant setting
Expert Panel: Anaemia, neutropenia, thrombocytopenia and cancer
Recent advances in multiple myeloma, featuring Educational Updates from ASH 2012
Clofarabine and other novel agents in AML; interview with Alan Burnett at ASH 2012
Advances in multiple myeloma from ASH 2012
Expert overview of hot news in lymphoma from ASH 2012 (2/2)